0000879169-24-000116.txt : 20240703
0000879169-24-000116.hdr.sgml : 20240703
20240703122001
ACCESSION NUMBER: 0000879169-24-000116
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240702
FILED AS OF DATE: 20240703
DATE AS OF CHANGE: 20240703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hoppenot Herve
CENTRAL INDEX KEY: 0001596492
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 241098926
MAIL ADDRESS:
STREET 1: C/O INCYTE CORPORATION-EXPERIMENTAL STN.
STREET 2: ROUTE 141 & HENRY CLAY RD., BLDG. E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
4
1
wk-form4_1720023594.xml
FORM 4
X0508
4
2024-07-02
0
0000879169
INCYTE CORP
INCY
0001596492
Hoppenot Herve
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
1
1
0
1
Chairman / CEO
President
0
Common Stock
2024-07-02
4
F
0
41723
59.02
D
460610
D
Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock.
This includes an aggregate of 84,467 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.
/s/ Elizabeth Feeney, Attorney-In-Fact
2024-07-03